Vaccination has relied on needles and syringes for more than a century, but new research suggests that this may soon change. Scientists are developing alternative vaccine delivery methods designed to make immunisation easier, less painful, and more accessible worldwide. These innovations could also improve vaccine distribution in low-resource settings and strengthen global outbreak response systems.
One of the most promising innovations is the use of microarray patches, small adhesive patches covered with microscopic projections that deliver vaccines through the skin without pain. These patches are designed to be lightweight, stable at higher temperatures, and potentially self-administered, making them especially useful in regions with limited healthcare workers or cold-chain infrastructure. Researchers are already testing patches for diseases such as measles, rubella, hepatitis B, tuberculosis, and HPV, with early trials showing strong acceptance among users and healthcare providers.
Respiratory vaccines delivered through nasal sprays or inhaled forms aim to stop infections where they begin—inside the nose and airways. Unlike injected vaccines, these methods can stimulate mucosal immunity, producing antibodies that act directly at infection sites. This approach could reduce transmission of respiratory diseases such as influenza, COVID-19, RSV, and tuberculosis, while also simplifying vaccine storage and delivery through dry-powder formulations.
Oral vaccines are already widely used for diseases like polio, cholera, and typhoid, but researchers are now developing next-generation versions targeting infections such as HPV, norovirus, and influenza. These vaccines could be taken as capsules, pills, or even delivered through genetically engineered edible plants like rice or lettuce. The main challenge is protecting vaccine ingredients from stomach acid, which is being addressed through protective coatings and nanoparticle delivery systems that help the vaccine survive digestion and reach immune cells in the gut.
Needle-free injection systems use high-pressure streams of liquid to deliver vaccines through the skin without puncturing it. These devices could reduce needle fear, eliminate needlestick injuries, and reduce medical waste. Although promising, challenges remain in controlling dosage depth and ensuring stability of sensitive vaccines such as mRNA-based formulations. Researchers are working on smart injector systems that adjust pressure and depth in real time.
Electroporation is a technique that uses small electrical pulses after injection to temporarily open cell membranes, allowing more vaccine material—particularly DNA-based vaccines—into cells. This can improve immune response and reduce the required dose. While still in development, this approach could help make DNA vaccines more effective, especially during large-scale outbreaks, although it requires specialised equipment.
Dry vaccine technologies, including freeze-dried powders, spray-dried particles, and dissolvable films, are being developed to reduce reliance on refrigeration. These formulations are more stable at higher temperatures and easier to transport, making them ideal for use in remote or low-resource areas. These dry forms could also be combined with patches, inhalers, or oral capsules, creating flexible vaccine delivery systems that do not depend on traditional cold-chain logistics. However, ensuring stability during the drying process remains a technical challenge, especially for advanced vaccines like mRNA-based platforms.
Together, these innovations point to a future where vaccination may no longer depend on needles. From skin patches and nasal sprays to oral capsules and dry formulations, next-generation vaccine technologies aim to improve accessibility, reduce barriers, and strengthen global health preparedness.
